Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Dialysis access · New York | Dialysis access · New Jersey | |
|---|---|---|
| Surgeons, 2024 | 109 | 58 |
| Medicare fee-for-service cases | 13,452 | 7,071 |
| Growth since 2019 (Medicare FFS) | −13%/yr | −13%/yr |
| Forecast cases (Medicare FFS) | 12,500 in 2030 | 7,590 in 2030 |
| Forecast growth | −1.2%/yr to 2030 | +1.2%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 7.7 | 7.0 |
| Medicare Advantage share | 57% | 45% |
| Out of hospital | 80% (+4 pts since 2019) | 70% (−1 pts since 2019) |
| Cases per surgeon | 123 | 122 |
| Top 10 surgeons' share | 43% | 68% |
| Surgeons growing | 10 | 4 |
| New since the base year | 17 | 6 |
| Likely to stop billing it | 24 by 2026 | 10 by 2026 |
| Forecast miss, 1 year (procedure) | 4% | 4% |
| Company payments per surgeon | $100 | $118 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.